These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8848943)

  • 21. Long-term efficacy and safety of lamotrigine monotherapy in Japanese and South Korean pediatric patients with newly diagnosed typical absence seizures: An open-label extension study.
    Yasumoto S; Ohtsuka Y; Sato K; Kurata A; Numachi Y; Shimizu M
    Brain Dev; 2018 Oct; 40(9):786-791. PubMed ID: 29861154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. aPTT prolongation and skin eruption possibly associated with lamotrigine monotherapy in a paediatric patient.
    Yeom JS; Park JS; Seo JH; Park ES; Lim JY; Park CH; Woo HO; Youn HS
    Epileptic Disord; 2011 Dec; 13(4):452-5. PubMed ID: 22258053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
    Hosford DA; Wang Y
    Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ezogabine treatment of childhood absence epilepsy.
    Vossler DG; Yilmaz U
    Epileptic Disord; 2014 Mar; 16(1):121-4. PubMed ID: 24659629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethosuximide in childhood absence epilepsy--older and better.
    Vining EP
    N Engl J Med; 2010 Mar; 362(9):843-5. PubMed ID: 20200390
    [No Abstract]   [Full Text] [Related]  

  • 26. Absence seizures in children.
    Posner E
    Clin Evid; 2003 Dec; (10):295-300. PubMed ID: 15555093
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lamotrigine in the therapy of resistant epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1999; 150(4):279-82. PubMed ID: 10605165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus anticoagulant induced by the combination of valproate and lamotrigine.
    Echaniz-Laguna A; Thiriaux A; Ruolt-Olivesi I; Marescaux C; Hirsch E
    Epilepsia; 1999 Nov; 40(11):1661-3. PubMed ID: 10565597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H; Krämer G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence seizures in children.
    Posner E
    Clin Evid; 2002 Dec; (8):236-41. PubMed ID: 12603880
    [No Abstract]   [Full Text] [Related]  

  • 31. Epilepsy with myoclonic absences.
    Manonmani V; Wallace SJ
    Arch Dis Child; 1994 Apr; 70(4):288-90. PubMed ID: 8185360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy.
    Penovich PE; Willmore LJ
    Epilepsia; 2009 Sep; 50 Suppl 8():37-41. PubMed ID: 19702732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An older drug for childhood absence epilepsy.
    Potera C
    Am J Nurs; 2010 Jun; 110(6):16. PubMed ID: 20505447
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Hwang H; Kim H; Kim SH; Kim SH; Lim BC; Chae JH; Choi JE; Kim KJ; Hwang YS
    Brain Dev; 2012 May; 34(5):344-8. PubMed ID: 21893390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of anticonvulsant therapy for absence epilepsy on heart function.
    Mamalyga ML
    Bull Exp Biol Med; 2014 Sep; 157(5):560-3. PubMed ID: 25257412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamotrigine ameliorates seizures and psychiatric comorbidity in a rat model of spontaneous absence epilepsy.
    Huang HY; Lee HW; Chen SD; Shaw FZ
    Epilepsia; 2012 Nov; 53(11):2005-14. PubMed ID: 22988820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamotrigine for intractable childhood epilepsy: a preliminary communication.
    Gibbs J; Appleton RE; Rosenbloom L; Yuen WC
    Dev Med Child Neurol; 1992 Apr; 34(4):369-71. PubMed ID: 1572524
    [No Abstract]   [Full Text] [Related]  

  • 38. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE; Walker JK; Lott RS; Shaw R; Speth J; Marty KJ; Rutecki P
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.